A leader in the care of pleural mesothelioma, Dr. David Sugarbaker, will direct the mesothelioma clinical and research program at the Lung Institute, a new comprehensive lung disease center at Baylor College of Medicine in Texas.
From a March 24, 2014 news report about Dr. Sugarbaker going to Baylor that was posted on BioNews Texas:
Sugarbaker comes to Baylor from Boston, where he served as professor of surgery at Harvard Medical School and chief of thoracic surgery at Brigham and Women’s Hospital. He will join the Baylor faculty this July and lead the new Lung Institute, multi-specialty center focused on lung disease, at Baylor College of Medicine…..
“Part of what attracted me to Baylor is the opportunity to build something that never has been done before,” he said. “I see a large role for clinical and translational research, with an eye to getting new treatments to patients as soon as possible. Baylor is a leader in genomic research and that will play a key part, as well as the personalized treatment of a patient’s lung disease. This program also will have a strong surgical presence.”…
Sugarbaker has led efforts in malignant pleural mesothelioma, including the banking of frozen samples of more than 1,500 mesotheliomas to help advance the research in molecular markers in the disease. He also has played a leading role in developing the clinical investigation of the role of surgery in cancer therapy trials.
We wish Dr. Sugarbaker the best in his new position at Baylor, and hope he has much success in finding new mesothelioma treatments for patients who have developed this tragic asbestos-related cancer.
Asbestos-Mesothelioma Case Evaluation Form
Free. Confidential. No Obligation.